These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 3159009

  • 1. Differential alteration of striatal D-1 and D-2 receptors induced by the long-term administration of haloperidol, sulpiride or clozapine to rats.
    Jenner P, Rupniak NM, Marsden CD.
    Psychopharmacology Suppl; 1985; 2():174-81. PubMed ID: 3159009
    [Abstract] [Full Text] [Related]

  • 2. Differential alterations in striatal dopamine receptor sensitivity induced by repeated administration of clinically equivalent doses of haloperidol, sulpiride or clozapine in rats.
    Rupniak NM, Kilpatrick G, Hall MD, Jenner P, Marsden CD.
    Psychopharmacology (Berl); 1984; 84(4):512-9. PubMed ID: 6441952
    [Abstract] [Full Text] [Related]

  • 3. Chronic treatment with clozapine, unlike haloperidol, does not induce changes in striatal D-2 receptor function in the rat.
    Rupniak NM, Hall MD, Mann S, Fleminger S, Kilpatrick G, Jenner P, Marsden CD.
    Biochem Pharmacol; 1985 Aug 01; 34(15):2755-63. PubMed ID: 4040370
    [Abstract] [Full Text] [Related]

  • 4. Changes in apomorphine-induced stereotypy as a result of subacute neuroleptic treatment correlates with increased D-2 receptors, but not with increases in D-1 receptors.
    Fleminger S, Rupniak NM, Hall MD, Jenner P, Marsden CD.
    Biochem Pharmacol; 1983 Oct 01; 32(19):2921-7. PubMed ID: 6138043
    [Abstract] [Full Text] [Related]

  • 5. Differential effects of continuous administration for 1 year of haloperidol or sulpiride on striatal dopamine function in the rat.
    Rupniak NM, Mann S, Hall MD, Fleminger S, Kilpatrick G, Jenner P, Marsden CD.
    Psychopharmacology (Berl); 1984 Oct 01; 84(4):503-11. PubMed ID: 6441951
    [Abstract] [Full Text] [Related]

  • 6. Differential alterations in striatal acetylcholine function in rats during 12 months' continuous administration of haloperidol, sulpiride, or clozapine.
    Rupniak NM, Briggs RS, Petersen MM, Mann S, Reavill C, Jenner P, Marsden CD.
    Clin Neuropharmacol; 1986 Oct 01; 9(3):282-92. PubMed ID: 3719573
    [Abstract] [Full Text] [Related]

  • 7. SCH 23390 may alter dopamine-mediated motor behaviour via striatal D-1 receptors.
    Boyce S, Kelly E, Davis A, Fleminger S, Jenner P, Marsden CD.
    Biochem Pharmacol; 1985 May 15; 34(10):1665-9. PubMed ID: 2988552
    [Abstract] [Full Text] [Related]

  • 8. Effects of acute and chronic treatments with clozapine and haloperidol on serotonin (5-HT2) and dopamine (D2) receptors in the rat brain.
    Wilmot CA, Szczepanik AM.
    Brain Res; 1989 May 22; 487(2):288-98. PubMed ID: 2525063
    [Abstract] [Full Text] [Related]

  • 9. Behavioral and biochemical aspects of neuroleptic-induced dopaminergic supersensitivity: studies with chronic clozapine and haloperidol.
    Seeger TF, Thal L, Gardner EL.
    Psychopharmacology (Berl); 1982 May 22; 76(2):182-7. PubMed ID: 6805029
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Regional blockade by neuroleptic drugs of in vivo 3H-spiperone binding in the rat brain. Relation to blockade of apomorphine induced hyperactivity and stereotypies.
    Köhler C, Haglund L, Ogren SO, Angeby T.
    J Neural Transm; 1981 May 22; 52(3):163-73. PubMed ID: 7198139
    [Abstract] [Full Text] [Related]

  • 14. Mesolimbic dopamine function is not altered during continuous chronic treatment of rats with typical or atypical neuroleptic drugs.
    Rupniak NM, Hall MD, Kelly E, Fleminger S, Kilpatrick G, Jenner P, Marsden CD.
    J Neural Transm; 1985 May 22; 62(3-4):249-66. PubMed ID: 2863324
    [Abstract] [Full Text] [Related]

  • 15. Long-term adaptive changes in striatal dopamine function in response to chronic neuroleptic intake in rats.
    Jenner P, Kerwin R, Rupniak NM, Murugaiah K, Hall MD, Fleminger S, Marsden CD.
    J Neural Transm Suppl; 1983 May 22; 18():205-12. PubMed ID: 6135741
    [Abstract] [Full Text] [Related]

  • 16. Alterations in cerebral glutamic acid decarboxylase and 3H-flunitrazepam binding during continuous treatment of rats for up to 1 year with haloperidol, sulpiride or clozapine.
    Rupniak NM, Prestwich SA, Horton RW, Jenner P, Marsden CD.
    J Neural Transm; 1987 May 22; 68(1-2):113-25. PubMed ID: 3806083
    [Abstract] [Full Text] [Related]

  • 17. Repeated administration of sulpiride for three weeks produces behavioural and biochemical evidence for cerebral dopamine receptor supersensitivity.
    Jenner P, Hall MD, Murugaiah K, Rupniak N, Theodorou A, Marsden CD.
    Biochem Pharmacol; 1982 Feb 01; 31(3):325-8. PubMed ID: 7200363
    [Abstract] [Full Text] [Related]

  • 18. Dopamine receptor subtypes: differential regulation after 8 months treatment with antipsychotic drugs.
    Florijn WJ, Tarazi FI, Creese I.
    J Pharmacol Exp Ther; 1997 Feb 01; 280(2):561-9. PubMed ID: 9023264
    [Abstract] [Full Text] [Related]

  • 19. Differences in the time course of dopaminergic supersensitivity following chronic administration of haloperidol, molindone, or sulpiride.
    Prosser ES, Pruthi R, Csernansky JG.
    Psychopharmacology (Berl); 1989 Feb 01; 99(1):109-16. PubMed ID: 2506596
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.